Compare AFLAC Incorporated (AFL) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AFLAC Incorporated vs 10X Genomics Inc — how do they compare? AFLAC Incorporated trades at $121.06 (market cap $60.70B), while 10X Genomics Inc trades at $59.24 (market cap $7.61B). The key difference: AFLAC Incorporated is far larger — about 8× 10X Genomics Inc's market cap, and AFLAC Incorporated pays a 2.02% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| AFL | TXG | |
|---|---|---|
Market Cap | $60.70B | $7.61B |
Sector | Financials | Health |
52-Week High | $129.55 | $58.57 |
52-Week Low | $103.55 | $11.34 |
Enterprise Value | $70.65B | $7.14B |
Dividend Yield | 2.02% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AFLAC Incorporated
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
